comparemela.com

Latest Breaking News On - Heng ren investments - Page 1 : comparemela.com

SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F

Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended.

Pakistan
Delaware
United-states
France
Shan-fu
Zhejiang
China
Bogota
Cundinamarca
Colombia
Massachusetts
Turkey

SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F

BEIJING (BUSINESS WIRE) Apr 29, 2024

Chile
Bogota
Cundinamarca
Colombia
Philippines
Weidong
Anhui
China
State-of-delaware
Delaware
United-states
Antigua-and-barbuda

SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F

BEIJING (BUSINESS WIRE) Apr 29, 2024

Shan-fu
Zhejiang
China
Turkey
France
Philippines
Enan-wang
Shaanxi
Antigua-and-barbuda
Delaware
United-states
Massachusetts

SINOVAC Reports Unaudited First Half of 2023 Financial Results

Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended June 30, 2023. First Half of 2023. -Today at 06:03 am- MarketScreener

Delaware
United-states
Antigua-and-barbuda
Colombia
Egypt
Kyrgyzstan
Massachusetts
China
State-of-delaware
Pakistan
India
Chiang-li

SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F

Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, has filed its 2022 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended. | May 1, 2023

China
State-of-delaware
Delaware
United-states
Antigua-and-barbuda
Beijing
Massachusetts
Chiang-li
Zhejiang
Indonesia
Hong-kong
Weidong

vimarsana © 2020. All Rights Reserved.